Jaclyn K Anderson

Years Active: 2017-2020
Publications (10 Years): 3

AbbVie Inc

University of Iowa (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

AbbVie Inc

United States

Medical Director

Education History

University of Iowa

United States

MSC

Peru State College

United States

BSC

Publications

Phillip J Mease, Apinya Lertratanakul, Jaclyn K Anderson, Kim Papp, Filip Van den Bosch, Shigeyoshi Tsuji, Eva Dokoupilova, Mauro Keiserman, Xin Wang, Sheng Zhong, Reva M McCaskill, Patrick Zueger, Aileen L Pangan, William Tillett
Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2. Annals of the rheumatic diseases (2020)
Joachim Sieper, Robert Landewé, Marina Magrey, Jaclyn K Anderson, Sheng Zhong, Xin Wang, Apinya Lertratanakul
Predictors of remission in patients with non-radiographic axial spondyloarthritis receiving open-label adalimumab in the ABILITY-3 study. RMD open 5 (1) (2019)
Philip J Mease, Arthur Kavanaugh, Laura C Coates, Iain B McInnes, Maja Hojnik, Ying Zhang, Jaclyn K Anderson, Alexander P Dorr, Dafna D Gladman
Prediction and benefits of minimal disease activity in patients with psoriatic arthritis and active skin disease in the ADEPT trial. RMD open 3 (1) (2017)

Jaclyn K Anderson.css-eqlu8i{font-size:small;padding-left:4px;}